Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 83

1.

Assessment of financial decision making: an informant scale.

Campbell RC, Lichtenberg PA, Hall LN, Teresi JA, Ocepek-Welikson K.

J Elder Abuse Negl. 2018 Dec 20:1-14. doi: 10.1080/08946566.2018.1556762. [Epub ahead of print]

PMID:
30570450
2.

The dialysis orders objective structured clinical examination (OSCE): a formative assessment for nephrology fellows.

Prince LK, Campbell RC, Gao SW, Kendrick J, Lebrun CJ, Little DJ, Mahoney DL, Maursetter LA, Nee R, Saddler M, Watson MA, Yuan CM; Nephrology Education Research & Development Consortium.

Clin Kidney J. 2018 Apr;11(2):149-155. doi: 10.1093/ckj/sfx082. Epub 2017 Aug 23.

3.

Effects of Intensive Blood Pressure Treatment on Acute Kidney Injury Events in the Systolic Blood Pressure Intervention Trial (SPRINT).

Rocco MV, Sink KM, Lovato LC, Wolfgram DF, Wiegmann TB, Wall BM, Umanath K, Rahbari-Oskoui F, Porter AC, Pisoni R, Lewis CE, Lewis JB, Lash JP, Katz LA, Hawfield AT, Haley WE, Freedman BI, Dwyer JP, Drawz PE, Dobre M, Cheung AK, Campbell RC, Bhatt U, Beddhu S, Kimmel PL, Reboussin DM, Chertow GM; SPRINT Research Group.

Am J Kidney Dis. 2018 Mar;71(3):352-361. doi: 10.1053/j.ajkd.2017.08.021. Epub 2017 Nov 20.

PMID:
29162340
4.

Influence of Baseline Diastolic Blood Pressure on Effects of Intensive Compared With Standard Blood Pressure Control.

Beddhu S, Chertow GM, Cheung AK, Cushman WC, Rahman M, Greene T, Wei G, Campbell RC, Conroy M, Freedman BI, Haley W, Horwitz E, Kitzman D, Lash J, Papademetriou V, Pisoni R, Riessen E, Rosendorff C, Watnick SG, Whittle J, Whelton PK; SPRINT Research Group.

Circulation. 2018 Jan 9;137(2):134-143. doi: 10.1161/CIRCULATIONAHA.117.030848. Epub 2017 Oct 11.

5.

Posterolateral Fusion Versus Interbody Fusion for Degenerative Spondylolisthesis: Systematic Review and Meta-Analysis.

Campbell RC, Mobbs RJ, Lu VM, Xu J, Rao PJ, Phan K.

Global Spine J. 2017 Aug;7(5):482-490. doi: 10.1177/2192568217701103. Epub 2017 May 31. Review.

6.

The AKI Clinic for Fragile Patients.

Yee J, Campbell RC.

Adv Chronic Kidney Dis. 2017 Jul;24(4):189-191. doi: 10.1053/j.ackd.2017.06.003. No abstract available.

PMID:
28778356
7.

The Interdisciplinary Chronic Kidney Disease Clinic: End of the Beginning, Not Beginning of the End.

Yee J, Campbell RC.

Am J Nephrol. 2017;45(6):461-463. doi: 10.1159/000475770. Epub 2017 May 13. No abstract available.

8.

Extraction of Unerupted Maxillary Canine Teeth in a Maned Wolf (Chrysocyon brachyurus).

Pessoa LMB, Roza M, Farias A, de Jesus PH, Campbell RC, de Pinho MP.

Case Rep Vet Med. 2016 Jul 11;2016:2827647. doi: 10.1155/2016/2827647. eCollection 2016.

9.

Engineers' Responsibilities for Global Electronic Waste: Exploring Engineering Student Writing Through a Care Ethics Lens.

Campbell RC, Wilson D.

Sci Eng Ethics. 2017 Apr;23(2):591-622. doi: 10.1007/s11948-016-9781-2. Epub 2016 Jul 1.

10.

Intensive vs Standard Blood Pressure Control and Cardiovascular Disease Outcomes in Adults Aged ≥75 Years: A Randomized Clinical Trial.

Williamson JD, Supiano MA, Applegate WB, Berlowitz DR, Campbell RC, Chertow GM, Fine LJ, Haley WE, Hawfield AT, Ix JH, Kitzman DW, Kostis JB, Krousel-Wood MA, Launer LJ, Oparil S, Rodriguez CJ, Roumie CL, Shorr RI, Sink KM, Wadley VG, Whelton PK, Whittle J, Woolard NF, Wright JT Jr, Pajewski NM; SPRINT Research Group.

JAMA. 2016 Jun 28;315(24):2673-82. doi: 10.1001/jama.2016.7050.

11.

Antiproteinuric therapy and Fabry nephropathy: factors associated with preserved kidney function during agalsidase-beta therapy.

Warnock DG, Thomas CP, Vujkovac B, Campbell RC, Charrow J, Laney DA, Jackson LL, Wilcox WR, Wanner C.

J Med Genet. 2015 Dec;52(12):860-6. doi: 10.1136/jmedgenet-2015-103471. Epub 2015 Oct 21.

12.

Interdisciplinary care clinics in chronic kidney disease.

Johns TS, Yee J, Smith-Jules T, Campbell RC, Bauer C.

BMC Nephrol. 2015 Oct 12;16:161. doi: 10.1186/s12882-015-0158-6. Review.

13.

Consistency of arsenic speciation in global tobacco products with implications for health and regulation.

Campbell RC, Stephens WE, Meharg AA.

Tob Induc Dis. 2014 Dec 11;12(1):24. doi: 10.1186/s12971-014-0024-5. eCollection 2014.

14.

Controls on the valence species of arsenic in tobacco smoke: XANES investigation with implications for health and regulation.

Campbell RC, Stephens WE, Finch AA, Geraki K.

Environ Sci Technol. 2014 Mar 18;48(6):3449-56. doi: 10.1021/es4039243. Epub 2014 Feb 26.

PMID:
24521490
15.

Education in CKD--learning in the 21st century.

Sturdivant RL, Campbell RC, Ullian ME.

Adv Chronic Kidney Dis. 2013 Jul;20(4):300-1. doi: 10.1053/j.ackd.2013.04.006. No abstract available.

PMID:
23809281
16.

Avoiding conflicting requirements: development of home healthcare devices through an interdisciplinary approach.

Johnson CR, Campbell RC.

Biomed Instrum Technol. 2013 Spring;Suppl:49-52. doi: 10.2345/0899-8205-47.s1.49. No abstract available.

PMID:
23600425
17.

High sodium:potassium intake ratio increases the risk for all-cause mortality: the REasons for Geographic And Racial Differences in Stroke (REGARDS) study.

Judd SE, Aaron KJ, Letter AJ, Muntner P, Jenny NS, Campbell RC, Kabagambe EK, Levitan EB, Levine DA, Shikany JM, Safford M, Lackland DT.

J Nutr Sci. 2013 Apr 23;2:e13. doi: 10.1017/jns.2013.4. eCollection 2013.

18.

The impact of disease activity, pain, disability and treatments on fatigue in established rheumatoid arthritis.

Campbell RC, Batley M, Hammond A, Ibrahim F, Kingsley G, Scott DL.

Clin Rheumatol. 2012 Apr;31(4):717-22. doi: 10.1007/s10067-011-1887-y. Epub 2011 Nov 29.

PMID:
22124789
19.

Association of dietary sodium and potassium intakes with albuminuria in normal-weight, overweight, and obese participants in the Reasons for Geographic and Racial Differences in Stroke (REGARDS) Study.

Aaron KJ, Campbell RC, Judd SE, Sanders PW, Muntner P.

Am J Clin Nutr. 2011 Oct;94(4):1071-8. doi: 10.3945/ajcn.111.013094. Epub 2011 Aug 31.

20.

Impact of chronic kidney disease on activities of daily living in community-dwelling older adults.

Bowling CB, Sawyer P, Campbell RC, Ahmed A, Allman RM.

J Gerontol A Biol Sci Med Sci. 2011 Jun;66(6):689-94. doi: 10.1093/gerona/glr043. Epub 2011 Mar 31.

21.

Hypokalemia and outcomes in patients with chronic heart failure and chronic kidney disease: findings from propensity-matched studies.

Bowling CB, Pitt B, Ahmed MI, Aban IB, Sanders PW, Mujib M, Campbell RC, Love TE, Aronow WS, Allman RM, Bakris GL, Ahmed A.

Circ Heart Fail. 2010 Mar;3(2):253-60. doi: 10.1161/CIRCHEARTFAILURE.109.899526. Epub 2010 Jan 26.

22.

Mineralocorticoid receptor blockers and chronic kidney disease.

Jain G, Campbell RC, Warnock DG.

Clin J Am Soc Nephrol. 2009 Oct;4(10):1685-91. doi: 10.2215/CJN.01340209. Epub 2009 Sep 3. Review.

23.

Mild hyperkalemia and outcomes in chronic heart failure: a propensity matched study.

Ahmed MI, Ekundayo OJ, Mujib M, Campbell RC, Sanders PW, Pitt B, Perry GJ, Bakris G, Aban I, Love TE, Aronow WS, Ahmed A.

Int J Cardiol. 2010 Oct 29;144(3):383-8. doi: 10.1016/j.ijcard.2009.04.041. Epub 2009 Jun 5.

24.

Effects of diabetes mellitus in patients with heart failure and chronic kidney disease: a propensity-matched study of multimorbidity in chronic heart failure.

Ritchie C, Ekundayo OJ, Muchimba M, Campbell RC, Frank SJ, Liu B, Aban IB, Ahmed A.

Int J Cardiol. 2009 May 29;134(3):330-5. doi: 10.1016/j.ijcard.2008.12.089. Erratum in: Int J Cardiol. 2010 Jan 7;138(1):106.

25.

Multimorbidity due to diabetes mellitus and chronic kidney disease and outcomes in chronic heart failure.

Ekundayo OJ, Muchimba M, Aban IB, Ritchie C, Campbell RC, Ahmed A.

Am J Cardiol. 2009 Jan 1;103(1):88-92. doi: 10.1016/j.amjcard.2008.08.035. Epub 2008 Oct 23.

26.

Epidemiology of chronic kidney disease in heart failure.

Ahmed A, Campbell RC.

Heart Fail Clin. 2008 Oct;4(4):387-99. doi: 10.1016/j.hfc.2008.03.008.

27.

Association of chronic kidney disease with outcomes in chronic heart failure: a propensity-matched study.

Campbell RC, Sui X, Filippatos G, Love TE, Wahle C, Sanders PW, Ahmed A.

Nephrol Dial Transplant. 2009 Jan;24(1):186-93. doi: 10.1093/ndt/gfn445. Epub 2008 Aug 18.

28.

A propensity-matched study of low serum potassium and mortality in older adults with chronic heart failure.

Alper AB, Campbell RC, Anker SD, Bakris G, Wahle C, Love TE, Hamm LL, Mujib M, Ahmed A.

Int J Cardiol. 2009 Sep 11;137(1):1-8. doi: 10.1016/j.ijcard.2008.05.047. Epub 2008 Aug 8. Erratum in: Int J Cardiol. 2010 Nov 19;145(2):409. Int J Cardiol. 2010 Nov 19;145(2):409.

29.

Inorganic arsenic levels in rice milk exceed EU and US drinking water standards.

Meharg AA, Deacon C, Campbell RC, Carey AM, Williams PN, Feldmann J, Raab A.

J Environ Monit. 2008 Apr;10(4):428-31. doi: 10.1039/b800981c. Epub 2008 Mar 7.

PMID:
18385862
30.

Standard versus high-dose CVVHDF for ICU-related acute renal failure.

Tolwani AJ, Campbell RC, Stofan BS, Lai KR, Oster RA, Wille KM.

J Am Soc Nephrol. 2008 Jun;19(6):1233-8. doi: 10.1681/ASN.2007111173. Epub 2008 Mar 12.

31.

Prevalence and characteristics of a family history of end-stage renal disease among adults in the United States population: Reasons for Geographic and Racial Differences in Stroke (REGARDS) renal cohort study.

McClellan W, Speckman R, McClure L, Howard V, Campbell RC, Cushman M, Audhya P, Howard G, Warnock DG.

J Am Soc Nephrol. 2007 Apr;18(4):1344-52. Epub 2007 Mar 7.

32.

Magnetic resonance spectroscopy detects brain injury and predicts cognitive functioning in children with brain injuries.

Yeo RA, Phillips JP, Jung RE, Brown AJ, Campbell RC, Brooks WM.

J Neurotrauma. 2006 Oct;23(10):1427-35.

PMID:
17020480
33.

Racial differences in the prevalence of chronic kidney disease among participants in the Reasons for Geographic and Racial Differences in Stroke (REGARDS) Cohort Study.

McClellan W, Warnock DG, McClure L, Campbell RC, Newsome BB, Howard V, Cushman M, Howard G.

J Am Soc Nephrol. 2006 Jun;17(6):1710-5. Epub 2006 Apr 26.

34.

Prevalence of chronic kidney disease and anemia among participants in the Reasons for Geographic and Racial Differences in Stroke (REGARDS) Cohort Study: baseline results.

Warnock DG, McClellan W, McClure LA, Newsome B, Campbell RC, Audhya P, Cushman M, Howard VJ, Howard G.

Kidney Int. 2005 Oct;68(4):1427-31. No abstract available.

35.

The renin-angiotensin system: a 21st century perspective.

Campbell RC.

J Am Soc Nephrol. 2004 Jul;15(7):1963-4. No abstract available.

36.

Oxidative stress in hypertension and chronic kidney disease: role of angiotensin II.

Agarwal R, Campbell RC, Warnock DG.

Semin Nephrol. 2004 Mar;24(2):101-14. Review.

PMID:
15017522
37.

Clinical alert: failure in face of mask seal as a consequence of incorrect face mask assembly.

McDouall SF, Campbell RC, Tasker RC.

Br J Anaesth. 2003 Dec;91(6):924-5. No abstract available.

38.

Proteinuria in diabetic nephropathy: treatment and evolution.

Campbell RC, Ruggenenti P, Remuzzi G.

Curr Diab Rep. 2003 Dec;3(6):497-504. Review.

PMID:
14611747
39.

Halting the progression of chronic nephropathy.

Campbell RC, Ruggenenti P, Remuzzi G.

J Am Soc Nephrol. 2002 Nov;13 Suppl 3:S190-5. Review.

40.

The ASA Physical Status Classification: inter-observer consistency. American Society of Anesthesiologists.

Mak PH, Campbell RC, Irwin MG; American Society of Anesthesiologists.

Anaesth Intensive Care. 2002 Oct;30(5):633-40.

41.

Halting the progression of renal disease: where we stand?

Campbell RC, Remuzzi G.

Nefrologia. 2002;22(4):303-5. No abstract available.

42.

Simplified citrate anticoagulation for continuous renal replacement therapy.

Tolwani AJ, Campbell RC, Schenk MB, Allon M, Warnock DG.

Kidney Int. 2001 Jul;60(1):370-4.

43.

Patient maintained alfentanil target-controlled infusion for analgesia during extracorporeal shock wave lithotripsy.

Irwin MG, Campbell RC, Lun TS, Yang JC.

Can J Anaesth. 1996 Sep;43(9):919-24.

PMID:
8874909
44.

A question of sunglasses.

Campbell Rc.

CLAO J. 1996 Apr;22(2):94. No abstract available.

PMID:
8728612
45.

Analysis of tasks performed by certified ophthalmic medical personnel.

Woodworth KE Jr, Campbell RC, Dean CA, DuBois LG, Ledford JK.

Ophthalmology. 1995 Dec;102(12):1973-86.

PMID:
9098305
46.

Ondansetron and minor oral surgery.

Campbell RC, Rodrigo MR.

Anaesth Intensive Care. 1995 Aug;23(4):516. No abstract available.

PMID:
7485954
47.

Rotation fasciocutaneous flap repair of lower limb defects.

Healy C, Tiernan E, Lamberty BG, Campbell RC.

Plast Reconstr Surg. 1995 Feb;95(2):243-51.

PMID:
7824603
48.

Contact lens practice in the managed care environment.

Campbell RC.

CLAO J. 1994 Oct;20(4):212-3. No abstract available.

PMID:
7820914
49.

Ondansetron for prevention of postoperative nausea and vomiting following minor oral surgery: a double-blind randomized study.

Rodrigo MR, Campbell RC, Chow J, Tong CK, Hui E, Lueveswanij S.

Anaesth Intensive Care. 1994 Oct;22(5):576-9.

PMID:
7632207
50.

Planning for uncertainty.

Campbell RC.

CLAO J. 1993 Jul;19(3):146. No abstract available.

PMID:
8375033

Supplemental Content

Loading ...
Support Center